BioRelix Inc.
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on BioRelix Inc.
In Vivo
At a January 2012 Goldman Sachs CEO conference, Merck & Co. Inc. CEO Ken Frazier, noting his company’s poor investor return in 2011 relative to its peers, acknowledged the company’s shortcomings f
Scrip
In Vitro Diagnostics Linkage Biosciences Inc. Linkage Biosciences gets $2.1mm in Series B funding Linkage Biosciences Inc. (developing tissue-typing molecular diagnostics) brought in $2.1mm via it
In Vivo
In Vitro Diagnostics Acquisitions /In Vitro Diagnostics Cepheid Novartis AG Novartis AG has licensed exclusive rights to Cepheid 's (DNA analysis) Xpert BCR-ABL assay, which monitors the BCR-